Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome

Xinglong Wang, Mike Snape, Eric Klann, Jeremy G. Stone, Avneet Singh, Robert B. Petersen, Rudy J. Castellani, Gemma Casadesus, Mark A. Smith, Xiongwei Zhu

Research output: Contribution to journalArticle

Abstract

Fragile X syndrome (FXS) is a developmental disorder caused by the loss of Fragile X Mental Retardation 1 (FMR1) gene function because of a CGG repeat expansion (> 200 repeats) in the gene. The molecular mechanism(s) linking loss of FMR1 function to the molecular pathology and cognitive/ behavioral disability remain unclear. Given the critical role of extracellular signal-regulated kinase (ERK) in synaptic plasticity and neurodevelopment, a number of recent studies have investigated ERK phosphorylation under basal conditions or upon mGluR-induction using neuronal and peripheral tissues from Fmr1 knockout mice and peripheral tissues from FXS patients. However, these reports have presented conflicting results. The current study is the first to focus on the levels of ERK phosphorylation in brain tissue from human FXS patients. In both human brain tissue and brain tissue from Fmr1 knockout mice there was significantly increased phosphorylation of MEK1/2 and ERK. Indeed, treating Fmr1 knockout mice with the MEK1/2 inhibitor SL327 abrogated audiogenic seizure activity, a feature of the Fmr1 knockout mice that replicates the symptom in patients with FXS. These findings suggest that activation of the ERK pathway results in some cardinal cognitive and clinical features in FXS patients and likely have profound translational implications.

Original languageEnglish (US)
Pages (from-to)672-679
Number of pages8
JournalJournal of Neurochemistry
Volume121
Issue number4
DOIs
StatePublished - May 2012

Fingerprint

Fragile X Syndrome
Extracellular Signal-Regulated MAP Kinases
Knockout Mice
Chemical activation
Phosphorylation
Tissue
Brain
Intellectual Disability
Genes
Neuronal Plasticity
Molecular Pathology
Mitogen-Activated Protein Kinase 1
Pathology
Plasticity
Seizures

Keywords

  • Audiogenic seizure
  • Extracellular signal-regulated kinase
  • Fragile X syndrome
  • Human postmortem brain tissues
  • MEK1/2

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome. / Wang, Xinglong; Snape, Mike; Klann, Eric; Stone, Jeremy G.; Singh, Avneet; Petersen, Robert B.; Castellani, Rudy J.; Casadesus, Gemma; Smith, Mark A.; Zhu, Xiongwei.

In: Journal of Neurochemistry, Vol. 121, No. 4, 05.2012, p. 672-679.

Research output: Contribution to journalArticle

Wang, X, Snape, M, Klann, E, Stone, JG, Singh, A, Petersen, RB, Castellani, RJ, Casadesus, G, Smith, MA & Zhu, X 2012, 'Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome', Journal of Neurochemistry, vol. 121, no. 4, pp. 672-679. https://doi.org/10.1111/j.1471-4159.2012.07722.x
Wang, Xinglong ; Snape, Mike ; Klann, Eric ; Stone, Jeremy G. ; Singh, Avneet ; Petersen, Robert B. ; Castellani, Rudy J. ; Casadesus, Gemma ; Smith, Mark A. ; Zhu, Xiongwei. / Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome. In: Journal of Neurochemistry. 2012 ; Vol. 121, No. 4. pp. 672-679.
@article{04b12d9f67004c61bb9c2636a62ab015,
title = "Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome",
abstract = "Fragile X syndrome (FXS) is a developmental disorder caused by the loss of Fragile X Mental Retardation 1 (FMR1) gene function because of a CGG repeat expansion (> 200 repeats) in the gene. The molecular mechanism(s) linking loss of FMR1 function to the molecular pathology and cognitive/ behavioral disability remain unclear. Given the critical role of extracellular signal-regulated kinase (ERK) in synaptic plasticity and neurodevelopment, a number of recent studies have investigated ERK phosphorylation under basal conditions or upon mGluR-induction using neuronal and peripheral tissues from Fmr1 knockout mice and peripheral tissues from FXS patients. However, these reports have presented conflicting results. The current study is the first to focus on the levels of ERK phosphorylation in brain tissue from human FXS patients. In both human brain tissue and brain tissue from Fmr1 knockout mice there was significantly increased phosphorylation of MEK1/2 and ERK. Indeed, treating Fmr1 knockout mice with the MEK1/2 inhibitor SL327 abrogated audiogenic seizure activity, a feature of the Fmr1 knockout mice that replicates the symptom in patients with FXS. These findings suggest that activation of the ERK pathway results in some cardinal cognitive and clinical features in FXS patients and likely have profound translational implications.",
keywords = "Audiogenic seizure, Extracellular signal-regulated kinase, Fragile X syndrome, Human postmortem brain tissues, MEK1/2",
author = "Xinglong Wang and Mike Snape and Eric Klann and Stone, {Jeremy G.} and Avneet Singh and Petersen, {Robert B.} and Castellani, {Rudy J.} and Gemma Casadesus and Smith, {Mark A.} and Xiongwei Zhu",
year = "2012",
month = "5",
doi = "10.1111/j.1471-4159.2012.07722.x",
language = "English (US)",
volume = "121",
pages = "672--679",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome

AU - Wang, Xinglong

AU - Snape, Mike

AU - Klann, Eric

AU - Stone, Jeremy G.

AU - Singh, Avneet

AU - Petersen, Robert B.

AU - Castellani, Rudy J.

AU - Casadesus, Gemma

AU - Smith, Mark A.

AU - Zhu, Xiongwei

PY - 2012/5

Y1 - 2012/5

N2 - Fragile X syndrome (FXS) is a developmental disorder caused by the loss of Fragile X Mental Retardation 1 (FMR1) gene function because of a CGG repeat expansion (> 200 repeats) in the gene. The molecular mechanism(s) linking loss of FMR1 function to the molecular pathology and cognitive/ behavioral disability remain unclear. Given the critical role of extracellular signal-regulated kinase (ERK) in synaptic plasticity and neurodevelopment, a number of recent studies have investigated ERK phosphorylation under basal conditions or upon mGluR-induction using neuronal and peripheral tissues from Fmr1 knockout mice and peripheral tissues from FXS patients. However, these reports have presented conflicting results. The current study is the first to focus on the levels of ERK phosphorylation in brain tissue from human FXS patients. In both human brain tissue and brain tissue from Fmr1 knockout mice there was significantly increased phosphorylation of MEK1/2 and ERK. Indeed, treating Fmr1 knockout mice with the MEK1/2 inhibitor SL327 abrogated audiogenic seizure activity, a feature of the Fmr1 knockout mice that replicates the symptom in patients with FXS. These findings suggest that activation of the ERK pathway results in some cardinal cognitive and clinical features in FXS patients and likely have profound translational implications.

AB - Fragile X syndrome (FXS) is a developmental disorder caused by the loss of Fragile X Mental Retardation 1 (FMR1) gene function because of a CGG repeat expansion (> 200 repeats) in the gene. The molecular mechanism(s) linking loss of FMR1 function to the molecular pathology and cognitive/ behavioral disability remain unclear. Given the critical role of extracellular signal-regulated kinase (ERK) in synaptic plasticity and neurodevelopment, a number of recent studies have investigated ERK phosphorylation under basal conditions or upon mGluR-induction using neuronal and peripheral tissues from Fmr1 knockout mice and peripheral tissues from FXS patients. However, these reports have presented conflicting results. The current study is the first to focus on the levels of ERK phosphorylation in brain tissue from human FXS patients. In both human brain tissue and brain tissue from Fmr1 knockout mice there was significantly increased phosphorylation of MEK1/2 and ERK. Indeed, treating Fmr1 knockout mice with the MEK1/2 inhibitor SL327 abrogated audiogenic seizure activity, a feature of the Fmr1 knockout mice that replicates the symptom in patients with FXS. These findings suggest that activation of the ERK pathway results in some cardinal cognitive and clinical features in FXS patients and likely have profound translational implications.

KW - Audiogenic seizure

KW - Extracellular signal-regulated kinase

KW - Fragile X syndrome

KW - Human postmortem brain tissues

KW - MEK1/2

UR - http://www.scopus.com/inward/record.url?scp=84859780333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859780333&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2012.07722.x

DO - 10.1111/j.1471-4159.2012.07722.x

M3 - Article

C2 - 22393900

AN - SCOPUS:84859780333

VL - 121

SP - 672

EP - 679

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 4

ER -